Margaret K. King

990 total citations
11 papers, 783 citations indexed

About

Margaret K. King is a scholar working on Genetics, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Margaret K. King has authored 11 papers receiving a total of 783 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Cognitive Neuroscience. Recurrent topics in Margaret K. King's work include Genetics and Neurodevelopmental Disorders (6 papers), Autism Spectrum Disorder Research (4 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Margaret K. King is often cited by papers focused on Genetics and Neurodevelopmental Disorders (6 papers), Autism Spectrum Disorder Research (4 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). Margaret K. King collaborates with scholars based in United States and Spain. Margaret K. King's co-authors include Richard S. Jope, Eléonore Beurel, Marjelo A. Mines, Christopher J. Yuskaitis, Marta Pardo, Courtney A. Miller, J. David Sweatt, Yuyan Cheng, Ana Martı́nez and Valle Palomo and has published in prestigious journals such as PLoS ONE, NeuroImage and Biological Psychiatry.

In The Last Decade

Margaret K. King

11 papers receiving 773 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Margaret K. King 452 380 375 150 66 11 783
Prescott T. Leach 345 0.8× 356 0.9× 430 1.1× 232 1.5× 58 0.9× 22 819
Nghiem Bui 380 0.8× 384 1.0× 333 0.9× 281 1.9× 60 0.9× 9 829
Deanna Graham 330 0.7× 357 0.9× 304 0.8× 256 1.7× 57 0.9× 8 783
Benjamin Rein 249 0.6× 254 0.7× 261 0.7× 139 0.9× 53 0.8× 20 692
Jessica A. Burket 364 0.8× 418 1.1× 381 1.0× 318 2.1× 67 1.0× 49 1000
Jane Yip 216 0.5× 319 0.8× 172 0.5× 205 1.4× 27 0.4× 10 539
Joseph A. Gogos 247 0.5× 180 0.5× 406 1.1× 228 1.5× 27 0.4× 8 704
Johannes Schumacher 273 0.6× 249 0.7× 249 0.7× 352 2.3× 56 0.8× 26 846
Christopher A. Chapleau 443 1.0× 323 0.8× 331 0.9× 265 1.8× 34 0.5× 22 824
Peter Zarevics 402 0.9× 535 1.4× 356 0.9× 349 2.3× 34 0.5× 11 994

Countries citing papers authored by Margaret K. King

Since Specialization
Citations

This map shows the geographic impact of Margaret K. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret K. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret K. King more than expected).

Fields of papers citing papers by Margaret K. King

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret K. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret K. King. The network helps show where Margaret K. King may publish in the future.

Co-authorship network of co-authors of Margaret K. King

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret K. King. A scholar is included among the top collaborators of Margaret K. King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret K. King. Margaret K. King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Budimirovic, Dejan B., Elizabeth Berry‐Kravis, Craig A. Erickson, et al.. (2017). Updated report on tools to measure outcomes of clinical trials in fragile X syndrome. Journal of Neurodevelopmental Disorders. 9(1). 14–14. 119 indexed citations
2.
Pardo, Marta, Margaret K. King, Emma Pérez‐Costas, et al.. (2015). Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3. Frontiers in Behavioral Neuroscience. 9. 55–55. 15 indexed citations
3.
Slane, Mylissa M., et al.. (2014). Social cognition, face processing, and oxytocin receptor single nucleotide polymorphisms in typically developing children. Developmental Cognitive Neuroscience. 9. 160–171. 25 indexed citations
4.
King, Margaret K., et al.. (2013). Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice. Biological Psychiatry. 75(3). 198–206. 91 indexed citations
5.
King, Margaret K., et al.. (2013). Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments. Pharmacology & Therapeutics. 141(1). 1–12. 145 indexed citations
6.
Mines, Marjelo A., Christopher J. Yuskaitis, Margaret K. King, Eléonore Beurel, & Richard S. Jope. (2010). GSK3 Influences Social Preference and Anxiety-Related Behaviors during Social Interaction in a Mouse Model of Fragile X Syndrome and Autism. PLoS ONE. 5(3). e9706–e9706. 173 indexed citations
7.
Knight, David C., et al.. (2009). Learning-related diminution of unconditioned SCR and fMRI signal responses. NeuroImage. 49(1). 843–848. 50 indexed citations
8.
Yuskaitis, Christopher J., Marjelo A. Mines, Margaret K. King, et al.. (2009). Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome. Biochemical Pharmacology. 79(4). 632–646. 152 indexed citations
9.
King, Margaret K., et al.. (2009). Adapting the process: Enablers and barriers to innovation in systems engineering and acquisition processes. 16. 360–365. 1 indexed citations
10.
King, Margaret K. & F. Warren McFarlan. (1997). we should, but don't paradox: exploring user acceptance of a business intelligence system. 1 indexed citations
11.
Rêves, J. G., et al.. (1978). Evidence for Existence of Intramyocardial Steal. Advances in experimental medicine and biology. 94. 755–760. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026